Get the Stockscreener App
0.9279
22.36%
0.1679
After Hours:
.95
0.0221
+2.38%
Inmed Pharmaceuticals Inc stock is traded at $0.9279, with a volume of 832.57K.
It is up +22.36% in the last 24 hours and down -7.01% over the past month.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
See More
Previous Close:
$0.76
Open:
$0.781
24h Volume:
832.57K
Relative Volume:
8.18
Market Cap:
$2.71M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0142
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
+4.34%
1M Performance:
-7.01%
6M Performance:
-55.51%
1Y Performance:
-64.84%
1-Day Range:
$0.781
$0.9529
1-Week Range:
$0.7321
$0.9529
52-Week Range:
$0.7321
$7.98
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals Inc
Sector
Phone
(604) 669-7207
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
0.9279 | 2.22M | 4.96M | -6.82M | -6.64M | -65.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.98 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.88 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Inmed Pharmaceuticals Inc Stock (INM) Latest News
INM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can InMed Pharmaceuticals Inc. reach all time highs this yearQuarterly Performance Summary & Technical Confirmation Trade Alerts - mfd.ru
Risk Off: Can InMed Pharmaceuticals Inc be the next market leaderMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
INM Should I Buy - Intellectia AI
Published on: 2026-02-27 15:19:59 - baoquankhu1.vn
Is InMed Pharmaceuticals Inc. undervalued by DCF analysis2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
Is InMed Pharmaceuticals Inc. (MWG) stock a contrarian opportunity2025 Market Outlook & Safe Entry Momentum Tips - mfd.ru
INM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Movers: Is InMed Pharmaceuticals Inc undervalued by DCF analysisMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures - TipRanks
InMed Pharmaceuticals Inc Reports Q2 2026 Financial Results and Business Update - TradingView
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Investing News Network
InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView
What analysts say about InMed Pharmaceuticals Inc. stockJuly 2025 Fed Impact & Verified Stock Trade Ideas - mfd.ru
What drives InMed Pharmaceuticals Inc.’s stock priceGlobal Markets & Verified Entry Point Detection - mfd.ru
Will InMed Pharmaceuticals Inc stock go up in YEAR2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Nasdaq Moves: What analysts say about InMed Pharmaceuticals Inc stockTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Can InMed Pharmaceuticals Inc. stock double in the next yearJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - mfd.ru
Aug Summary: Will InMed Pharmaceuticals Inc. stock go up in YEARJuly 2025 Selloffs & Weekly Chart Analysis and Guides - mfd.ru
Should I add InMed Pharmaceuticals Inc. stock to my portfolio2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Risk Analysis: What drives InMed Pharmaceuticals Incs stock price2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
InMed faces challenges from new US legislation - MSN
Chart Watch: What analysts say about InMed Pharmaceuticals Inc stockWeekly Trading Summary & Precise Buy Zone Identification - baoquankhu1.vn
Market Catalysts: What analysts say about InMed Pharmaceuticals Inc stockBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug PostEarnings: Does Nano X Imaging Ltd align with a passive investing strategy - baoquankhu1.vn
Performance Recap: Is InMed Pharmaceuticals Inc undervalued by DCF analysisWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Breakout Zone: Can InMed Pharmaceuticals Inc stock surprise with earnings upsideJuly 2025 Big Picture & Safe Capital Investment Plans - Bộ Nội Vụ
Returns Recap: Can InMed Pharmaceuticals Inc. stock beat analyst upgrades2025 Technical Overview & Consistent Profit Alerts - Улправда
Will InMed Pharmaceuticals Inc. (MWG) stock beat revenue estimates2025 Year in Review & Growth Focused Entry Reports - Улправда
Pullback Watch: Can InMed Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Watchlist for Hot Stocks - Улправда
What dividend safety score for InMed Pharmaceuticals Inc. stockQuarterly Earnings Review & Budget Friendly Portfolio - Улправда
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Indian Infotech and Software Limited At Critical Juncture Bounce or BreakdownGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
Risk Check: Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull market - Улправда
Surprises Report: What Wall Street predicts for InMed Pharmaceuticals Inc. stock price2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Growth Value: Why hedge funds are buying InMed Pharmaceuticals Inc. stock2025 Bull vs Bear & Real-Time Price Movement Reports - Улправда
Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Stepwise Trade Signal Implementation - Улправда
Day Trade: How analysts revise price targets for InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Why hedge funds are buying InMed Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Улправда
InMed Shareholders Approve Directors and Equity Financing Flexibility - TipRanks
InMed Pharmaceuticals (INM) investors approve directors, auditor and 20%+ SEPA share issuance - Stock Titan
InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network
Drug developer's investors sign off on potential 20% new share issuance - Stock Titan
InMed Pharmaceuticals (INM) director details employee stock option expiry - Stock Titan
InMed Pharmaceuticals (INM) CEO Eric Adams details 250-option expiry - Stock Titan
InMed Pharmaceuticals Inc. (INM) discloses COO stock option expiration - Stock Titan
InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET - TMX Newsfile
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TMX Newsfile
Dated alerts on InMed Pharmaceuticals withdrawn - marketscreener.com
InMed Faces Challenges from New U.S. Legislation - TipRanks
Inmed Pharmaceuticals Inc Stock (INM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):